Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Colorectal Neoplasms 45Stomach Neoplasms 23Pancreatic Neoplasms 22Rectal Neoplasms 16Esophageal Neoplasms 14Adenocarcinoma Of Esophagus 14Colonic Neoplasms 13Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Neoplasm Metastasis 10Urinary Bladder Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Esophageal Squamous Cell Carcinoma 7Adenocarcinoma 7Parkinson Disease 4, Autosomal Dominant Lewy Body 6Ovarian Neoplasms 5Cholangiocarcinoma 5Lung Neoplasms 4Endometrial Neoplasms 4Carcinoma, Hepatocellular 4Carcinoma 4Head and Neck Neoplasms 3Gastrointestinal Neoplasms 3Breast Neoplasms 3Biliary Tract Neoplasms 3Advanced Solid Tumors 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Oropharyngeal Neoplasms 2Melanoma 2

Interventions

Magnetic Resonance Spectroscopy 8Specimen Handling 5Nivolumab 5selpercatinib 4Iodine-124 4Biopsy 4pembrolizumab 3binimetinib 3Iodine-131 3Cetuximab 3ulixertinib 2trametinib 2omipalisib 2lenvatinib 2larotrectinib 2durvalumab 2defactinib 2dabrafenib 2Surveys and Questionnaires 2Sunitinib 2Radiosurgery 2Ipilimumab 2Immunoglobulin G 2Gemcitabine 2Disulfides 2Cyclophosphamide 2CTLA-4 Antigen 2tremelimumab 1trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thyroid Neoplasms × Fluorouracil × 90 days × Clear all
NCT05355701 2026-05-14

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Pfizer

Phase 1 Recruiting
267 enrolled
CNSDermatologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Glioma, Melanoma, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡